Gaurav Shah

Insider Reports History

Location
New York, NY
Signature
/s/ Martin Wilson, as attorney-in-fact for Gaurav Shah
All insider transactions
Transactions in reports broken out by “transaction date” reported in original SEC filing, see here for transactions aggregated across transaction date

Holdings reported by Gaurav Shah:

Company Role Class Num Shares Value Price $ Report Date Ownership
ROCKET PHARMACEUTICALS, INC. CEO, Director Stock Option (Right to Buy) 243,345 $3,659,909 $15.04 11 Feb 2025 Direct
ROCKET PHARMACEUTICALS, INC. CEO, Director Common Stock 778,296 $2,321,656 $2.98 18 Nov 2025 Direct
ROCKET PHARMACEUTICALS, INC. CEO, Director Common Stock 207,897 $790,008 $3.80 18 Nov 2025 By Spouse
ROCKET PHARMACEUTICALS, INC. CEO, Director Common Stock 198,341 $753,695 $3.80 18 Nov 2025 By Gaurav D. Shah Irrevocable Trust
Talaris Therapeutics, Inc. Director Stock Option (Right to Buy) 20,500 13 Jun 2023 Direct

Insider Reports Filed by Gaurav Shah

Symbol Company Period Transactions Value $ Form Type Role Filing Time
RCKT ROCKET PHARMACEUTICALS, INC. 18 Nov 2025 1 -$18,721 4 CEO, Director 20 Nov 2025, 16:05
RCKT ROCKET PHARMACEUTICALS, INC. 18 Aug 2025 1 -$6,814 4 CEO, Director 20 Aug 2025, 17:00
RCKT ROCKET PHARMACEUTICALS, INC. 20 May 2025 1 -$14,523 4 CEO, Director 22 May 2025, 16:05
RCKT ROCKET PHARMACEUTICALS, INC. 16 May 2025 1 -$23,638 4 CEO, Director 20 May 2025, 16:05
RCKT ROCKET PHARMACEUTICALS, INC. 10 Apr 2025 1 +$101,600 4 CEO, Director 14 Apr 2025, 18:57
RCKT ROCKET PHARMACEUTICALS, INC. 21 Feb 2025 1 -$172,486 4 CEO, Director 25 Feb 2025, 16:01
RCKT ROCKET PHARMACEUTICALS, INC. 11 Feb 2025 2 $0 4 CEO, Director 13 Feb 2025, 16:01
RCKT ROCKET PHARMACEUTICALS, INC. 21 Nov 2024 1 -$144,782 4 CEO, Director 25 Nov 2024, 16:05
RCKT ROCKET PHARMACEUTICALS, INC. 16 Aug 2024 1 -$178,564 4 CEO, Director 20 Aug 2024, 16:26
RCKT ROCKET PHARMACEUTICALS, INC. 14 May 2024 9 -$228,596 4 CEO, Director 20 May 2024, 16:33
RCKT ROCKET PHARMACEUTICALS, INC. 16 Feb 2024 3 -$604,876 4 CEO, Director 21 Feb 2024, 20:54
RCKT ROCKET PHARMACEUTICALS, INC. 14 Feb 2024 3 $0 4 CEO, Director 16 Feb 2024, 16:05
RCKT ROCKET PHARMACEUTICALS, INC. 14 Nov 2023 2 $0 4 CEO, Director 16 Nov 2023, 19:09
RCKT ROCKET PHARMACEUTICALS, INC. 17 Aug 2023 1 -$73,750 4 CEO, Director 21 Aug 2023, 16:05
RCKT ROCKET PHARMACEUTICALS, INC. 14 Aug 2023 2 $0 4 CEO, Director 15 Aug 2023, 16:06
TRML Talaris Therapeutics, Inc. 13 Jun 2023 1 $0 4 Director 14 Jun 2023, 19:01
RCKT ROCKET PHARMACEUTICALS, INC. 17 May 2023 1 -$88,108 4 CEO, Director 19 May 2023, 16:05
RCKT ROCKET PHARMACEUTICALS, INC. 14 May 2023 2 $0 4 CEO, Director 16 May 2023, 20:04
RCKT ROCKET PHARMACEUTICALS, INC. 17 Feb 2023 1 -$232,418 4 CEO, Director 22 Feb 2023, 18:27
RCKT ROCKET PHARMACEUTICALS, INC. 14 Feb 2023 4 $0 4/A CEO, Director 22 Feb 2023, 18:25
TRML Talaris Therapeutics, Inc. 09 Jun 2022 1 $0 4 Director 13 Jun 2022, 18:16
RCKT ROCKET PHARMACEUTICALS, INC. 14 Feb 2022 2 $0 4 CEO, Director 16 Feb 2022, 20:02
RCKT ROCKET PHARMACEUTICALS, INC. 07 Feb 2022 1 +$381,513 4 CEO, Director 08 Feb 2022, 15:43